article thumbnail

MSD receives FDA approval for Enflonsia to prevent RSV

Pharmaceutical Technology

MSD research laboratories president Dean Li stated: “Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season with the same dose regardless of weight. Can pharma tariffs “Make America Manufacture Again”?

article thumbnail

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Pharmaceutical Technology

MSD Research Laboratories global clinical development senior vice-president and head, chief medical officer Dr Eliav Barr stated: “MSD has been at the forefront of HIV research for more than 35 years and we are pleased to continue our work to innovate and deliver new options that aim to meet the needs of the HIV community.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA approves MSD’s Keytruda to treat head and neck cancer

Pharmaceutical Technology

Can pharma tariffs “Make America Manufacture Again”? GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

article thumbnail

Codivir Shows Promising Effect Against COVID-19

Pharma Mirror

In-vitro studies conducted at the British virology research laboratory Virology Research Services in London then demonstrated a potent antiviral activity against SARS-CoV-2 and other RNA viruses. The post Codivir Shows Promising Effect Against COVID-19 appeared first on Pharma Mirror Magazine. The trial was conducted at.

article thumbnail

Sterling Pharma Solutions Establishes Centre of Excellence in Continuous Flow Chemistry

Pharma Mirror

Multiple flow chemistry platforms have been installed into a research laboratory at the site to allow the investigation of a wide range of chemical processes, including photolysis, electrochemistry and hydrogenations, as well.

article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

The south-east performs consistently well, with South Carolina named the fourth best state for business climate by Area Development magazine in 2021. In the US, entry barriers and tax levels vary largely across states. South Carolina also has one of the lowest unionisation rates in the country (2.6%).